Section Arrow
Quote
CURX.NASDAQ
- Curanex Pharmaceuticals Inc.
(Financial Status)
Quotes are at least 15-min delayed:2026/04/28 00:30 EDT
Regular Hours
Last
 0.4257
-0.0113 (-2.59%)
Day High 
0.472 
Prev. Close
0.437 
1-M High
0.555 
Volume 
83.10K 
Bid
0.42
Ask
0.4516
Day Low
0.4201 
Open
0.472 
1-M Low
0.41 
Market Cap 
12.40M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.45 
20-SMA 0.47 
50-SMA 0.43 
52-W High 9.1796 
52-W Low 0.262 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.17/--
Enterprise Value
12.62M
Balance Sheet
Book Value Per Share
0.40
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.245+0.04+19.51%-- 
CMPXCompass Therapeutics1.79-3.24-64.41%-- 
ONCOOnconetix Inc.0.7421+0.1546+26.31%0PE
SGMTSagimet Biosciences8.12+2.26+38.57%-- 
HCWBHCW Biologics Inc0.439+0.0634+16.88%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.